Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving

Caring & giving

“My company makes the medication that helped me fight multiple myeloma”

Paul Reidy, a Johnson & Johnson warehouse technician in Ireland, never imagined that an oncology therapy made at the facility where he works would help save his life.

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 56 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

3 nurse practitioners who are filling critical gaps in healthcare

From using cutting-edge technology to address mental health issues to launching an urban clinic that helps treat substance-abuse disorders and taking an innovative approach to deliver rural medical care, learn how Johnson & Johnson is helping support a new generation of providers.

Featured stories

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

“My family and I volunteer on a floating hospital that delivers medical care”

Lee-Anne James is a Johnson & Johnson clinical research manager whose home base is Australia. That is, when she and her family aren’t donating their time to Mercy Ships to help treat people who lack access to lifesaving healthcare.

“Lung cancer wasn’t even on my radar. Then I was diagnosed.”

The disease is often detected late—which can have fatal consequences. But thanks to innovations in diagnostic tools, there’s a way to catch lung cancer earlier. Here’s how early detection saved one woman’s life.

More from Johnson & Johnson

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

What is inflammation?

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.

What is IL-23?

This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.